Angela Ianaro
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Retraction notice to "FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells" [Journal of Controlled Release 382 (2025) 113732].
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 09, 2026
Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors.
Journal: Frontiers in immunology
Published: September 15, 2025
FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 14, 2025
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: December 12, 2024
Paper-based electrochemical device for the determination of H₂S in murine lysates for liquid biopsy application.
Journal: Analytica chimica acta
Published: November 23, 2024
Olive leaf extract (OLE) reduces mast cell-mediated allergic inflammation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 13, 2024
Retraction notice to "Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation" [Eur. J. Pharmacol 483 (1) (2004) 79-93].
Journal: European journal of pharmacology
Published: September 19, 2024
Circulating innate lymphoid cells are dysregulated in patients with prostate cancer.
Journal: Cellular & molecular biology letters
Published: August 09, 2024
Nutraceutical formulation based on a synergic combination of melatonin and palmitoylethanolamide for the management of allergic events.
Journal: Frontiers in nutrition
Published: April 15, 2024
Immunohistochemical Expression of Glutathione Peroxidase-2 (Gpx-2) and Its Clinical Relevance in Colon Adenocarcinoma Patients.
Journal: International journal of molecular sciences
Published: August 05, 2023
Last Updated: 09/26/2026